硝苯地平联合依那普利治疗老年冠心病合并高血压临床分析被引量：3

导出

摘要目的:探讨硝苯地平联合依那普利治疗老年冠心病合并高血压的临床疗效。方法:对42例老年冠心病合并高血压患者采用硝苯地平联合依那普利治疗,并与单独采用硝苯地平治疗的42例患者进行临床疗效及不良反应的比较研究。结果:两组患者的收缩压和舒张压均较治疗前明显降低(P<0.05)。但两组治疗后收缩压、舒张压比较无显著性差异(P>0.05)。研究组患者治疗6个月内临床缺血事件发生率(14.29%)明显低于对照组(45.24%)(P<0.05)。结论:硝苯地平联合依那普利治疗老年冠心病合并高血压安全有效,不仅可以有效地控制血压,还可以降低临床缺血事件发生率,不良反应少,耐受性好,改善预后效果明显,值得推广应用。

作者张霞

机构地区遂宁市第一人民医院药剂科

出处《亚太传统医药》 2013年第11期180-181,共2页 Asia-Pacific Traditional Medicine

关键词硝苯地平依那普利老年冠心病高血压

分类号 R541.3 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献5

1杨习星,李宏林.硝苯地平缓释片(Ⅱ)联合依那普利对老年人冠心病合并高血压降压效果临床观察[J].陕西医学杂志,2011,40(7):882-883. 被引量：41
2张文光.尼群地平、美托洛尔、血塞通合用治疗老年高血压合并冠心病56例[J].中国医药指南,2011,9(9):226-227. 被引量：4
3施丽芳,骆秀婷,龙作湘,申源生,谢桂庭.老年高血压患者动态动脉硬化指数与心律失常的关系[J].广东医学,2011,32(6):746-748. 被引量：19
4邬松林,黄从新.氯沙坦对老年高血压患者室性心律失常的影响[J].中华老年医学杂志,2011,30(1):24-26. 被引量：15
5安京玉.缬沙坦与稳心颗粒治疗高血压并发心律失常的疗效观察[J].中国现代药物应用,2011,5(19):73-74. 被引量：4

二级参考文献22

1吕卓人,梁磊,艾文婷.血管紧张素Ⅱ1型受体拮抗剂研究进展[J].中华心血管病杂志,2004,32(11):1054-1056. 被引量：61
2张明华,覃秀川,刘国树,吕丽英.高血压病患者动脉硬化指数增高的相关因素分析[J].临床内科杂志,2007,24(3):176-178. 被引量：6
3Wachtell K, Gerdts E, Aurigemma GP, et al. Intreatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Blood Press, 2010,19 : 169-175.
4Nomura M, Kawano T, Nakayasu K, et al. The effects of losartan on signal-averaged P wave in patients with atrial fibrillation. Int J Cardiol, 2008, 126:21-27.
5Okin PM, Wachtell K, Kjeldsen SE, et al. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study. Circ Arrhythm Electrophysio1,2008,1 : 337 343.
6Butz S, Driamov S, Remondino A, et al. Losartan but not enalaprilat acutely reduces reperfusion ventricular tachyarrhythmias in hypertrophied rat hearts after low-flow ischaemia. J Pharm Pharmacol, 2004,56 .. 521-528.
7Wachtell K, I.ehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol, 2005,45 : 712-719.
8Gtinther S, Baba HA, Hauptmann S, et al. Losartan reduces mortality in a genetic model of heart failure. Naunyn Schmiedebergs Arch Pharmacol, 2010, 382: 2G5 278.
9Stein M, Boulaksil M, Jansen JA, et al. Reduction of fibrosis-related arrhythmias by chronic renin- angiotensin-aldosterone system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol, 2010,299:H310-321.
10Zakynthinos E, Pierrutsakos CH, Daniil Z, et al. I.osartan controlled blood pressure and reduced left ventricular hypertrophy but did not alter arrhythmias in hypertensive men with preserved systolic function. Angiology, 2005,56 : 439-449.